The success of Sildenafil initially sparked a period of growth for pharma, however recent changes present a uncertain scenario for investors. Generic alternatives are eating into earnings, and persistent patent https://joanqkio517572.thekatyblog.com/39371231/sildenafil-and-pharma-a-volatile-bet